Venkat Reddy has become chief scientific officer, and David Moffat, chief technology officer, at Macrophage Pharma Ltd as the company prepares to bring a candidate drug into the clinic. Macrophage is developing small molecule immunomodulators for cancer. Dr Reddy was most recently head of translational sciences at Glenmark Pharmaceuticals Ltd and before that, held positions at Pfizer Inc, Sanofi SA and the Novartis Institute for Functional Genomics. He earned a PhD in human biology at the Ludwig Maximilians University, Germany and did post-doctoral work at the Scripps Research Institute in the US. Dr Moffat is co-founder of Macrophage Pharma and co-inventor of the company’s technology platform. He holds a BSc in chemistry and a PhD in organic chemistry from the University of Glasgow, UK.
Macrophage Pharma announced the appointments on 9 January 2020.
Copyright 2020 Evernow Publishing Ltd